XML 28 R26.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS | 12 Months Ended
--- | ---
Dec. 31, 2019
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] |
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS | SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS
| Balance at Beginning of Period |  | Charged to Costs and Expenses |  | Other |  | Deductions |  | Balance at End of Period
Description |  |  |  |
| (In thousands) |  |
Year ended December 31, 2019 |  |  |  |  |  |  |  |  |
Allowance for doubtful accounts | 3,719 |  |  | 2,126 |  |  | — |  |  | (1,542 | ) | (2) | 4,303 |
Deferred tax assets valuation allowance | 6,973 |  |  | 3,848 |  |  | 1,291 |  | (4) | (43 | ) |  | 12,069 |
Year ended December 31, 2018 |  |  |  |  |  |  |  |  |
Allowance for doubtful accounts | $ | 8,882 |  |  | $ | 557 |  |  | $ | (4,649 | ) | (3) | $ | (1,071 | ) | (2) | $ | 3,719 |
Deferred tax assets valuation allowance | 7,961 |  |  | (894 | ) |  | — |  |  | (94 | ) |  | 6,973 |
Year ended December 31, 2017 |  |  |  |  |  |  |  |  |
Allowance for doubtful accounts and sales returns and allowances | $ | 6,319 |  |  | $ | 4,920 |  |  | $ | 1,518 |  | (1) | (3,875 | ) | (2) | $ | 8,882 |
Deferred tax assets valuation allowance | 3,604 |  |  | 740 |  |  | 3,617 |  | (1) | — |  |  | 7,961 |
(1) | The above amounts primarily relate to amounts acquired through acquisition of Derma Sciences and effect of foreign currency translations.
(2) | Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.
(3) | The Company transferred sales returns and allowances from accounts receivable, net to accrued expenses and other current liabilities upon adopting Topic 606 on January 1, 2018 using the modified retrospective method.
(4) The above amount primarily relates to amounts acquired through the acquisition of Arkis and a charge recorded in 2019 to valuation allowance related to the non-deductibility of executive compensation.

X
- Definition The entire disclosure for valuation and qualifying accounts and reserves. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 09 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SX 210.12-09) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690 + Details
Name: | srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | srt_ValuationAndQualifyingAccountsAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration